john[_5_]
February 4th 10, 08:30 AM
tip of the iceberg
http://www.foxnews.com/story/0,2933,584548,00.html
17 Canadians Sick From H1N1 Vaccine
Tuesday, February 02, 2010
Seventeen Canadians became sick after receiving the H1N1 flu vaccine, the
Toronto Sun reported.
Four people have Guillan-Barre syndrome, and 13 people had anaphylaxis, an
allergic reaction characterized by symptoms of anaphylactic shock, rapid
heartbeat, itching and/or difficulty breathing, said Andrew Morrison,
spokesman for the Ministry of Health and Long Term Care.
One recipient of the vaccine, Donna Hartlen, is a 39-year-old mother who is
suffering from Guillan-Barre syndrome. The right side of Hartlen's face is
now paralyzed and she is not able to chew food.
It is not known why Guillan-Barre syndrome, in which the body's immune
system attacks part of the peripheral nervous system, affects some people,
but not others.
Health Canada pulled a batch of the H1N1 vaccine, which was produced by
GlaxoSmithKline, when it appeared to produce higher rates of allergic
reactions compared to other batches.
http://www.foxnews.com/story/0,2933,584548,00.html
17 Canadians Sick From H1N1 Vaccine
Tuesday, February 02, 2010
Seventeen Canadians became sick after receiving the H1N1 flu vaccine, the
Toronto Sun reported.
Four people have Guillan-Barre syndrome, and 13 people had anaphylaxis, an
allergic reaction characterized by symptoms of anaphylactic shock, rapid
heartbeat, itching and/or difficulty breathing, said Andrew Morrison,
spokesman for the Ministry of Health and Long Term Care.
One recipient of the vaccine, Donna Hartlen, is a 39-year-old mother who is
suffering from Guillan-Barre syndrome. The right side of Hartlen's face is
now paralyzed and she is not able to chew food.
It is not known why Guillan-Barre syndrome, in which the body's immune
system attacks part of the peripheral nervous system, affects some people,
but not others.
Health Canada pulled a batch of the H1N1 vaccine, which was produced by
GlaxoSmithKline, when it appeared to produce higher rates of allergic
reactions compared to other batches.